Table 1.
Cohort Demographics and Relevant Clinical Characteristicsa
| Characteristics | n (%) |
|---|---|
| Median age (range): 78 (29-94), years | |
| <50 | 1 (6) |
| 50-70 | 2 (12) |
| 70-90 | 12 (70) |
| >90 | 2 (12) |
| Male | 15 (88) |
| Self-identified race | |
| Hispanic | 0 |
| Asian | 3 (18) |
| Black | 0 |
| White | 11 (64) |
| Unknown | 3 (18) |
| Comorbidities | |
| Hypertension | 9 (53) |
| Diabetes mellitus | 4 (23) |
| Obesity | 1 (6) |
| Cardiac disease (congestive heart failure/coronary artery disease) | 10 (59) |
| Cerebrovascular accident | 2 (12) |
| Cognitive decline | 7 (41) |
| Chronic obstructive pulmonary disease | 3 (18) |
| Cancer | 3 (18) |
| Chronic kidney disease | 1 (6) |
| None known | 1 (6) |
| Duration of hospitalization, d | |
| Deceased on arrival | 1 (6) |
| <1 | 4 (23) |
| 5-10 | 5 (29) |
| 10-15 | 2 (12) |
| 15-20 | 2 (12) |
| >20 | 3 (18) |
| Mechanical ventilation | 7 (41) |
| COVID-19 treatment | |
| Dexamethasone | 1 (6) |
| Remdesvir | 1 (6) |
| Remdesvir and dexamethasone | 2 (12) |
| Remdesvir and convalescent plasma | 2 (12) |
| Renal parameters | |
| AKI KDIGO stage | |
| 1 | 8 (47) |
| 2 | 2 (12) |
| 3 | 3 (18) |
| Undetermined | 4 (23) |
| Proteinuria, dipstick, mg | |
| <30 | 2 (12) |
| 30-50 | 7 (41) |
| 50-100 | 4 (23) |
| Unknown | 4 (23) |
a
AKI, acute kidney injury; COVID-19, coronavirus disease 2019; KDIGO, Kidney Disease Improving Global Outcomes.